Accelerate your immune checkpoint studies.
PD-1, expressed on activated T cells, binds to its ligands PD-L1 and PD-L2 on tumor and antigen-presenting cells — suppressing immune responses and promoting tumor escape.
From PD-1 to PD-L1 and PD-L2, explore a curated collection of reagents — including monoclonal antibodies, ELISA kits, and isotype controls — optimized for functional assays, expression analysis, and therapeutic target validation.
|
